|
MKNK1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.656600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.820400E-01 |
| Normal-vs-Stage2 |
5.193800E-01 |
| Normal-vs-Stage3 |
5.486400E-01 |
| Normal-vs-Stage4 |
6.250200E-01 |
| Stage1-vs-Stage2 |
7.512000E-02 |
| Stage1-vs-Stage3 |
6.207600E-01 |
| Stage1-vs-Stage4 |
6.458600E-01 |
| Stage2-vs-Stage3 |
2.247000E-01 |
| Stage2-vs-Stage4 |
3.077400E-01 |
| Stage3-vs-Stage4 |
9.456000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.003800E-01 |
| Normal-vs-AfricanAmerican |
3.798800E-01 |
| Normal-vs-Asian |
3.673000E-01 |
| Caucasian-vs-AfricanAmerican |
9.613800E-01 |
| Caucasian-vs-Asian |
8.425600E-01 |
| AfricanAmerican-vs-Asian |
9.217200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.928200E-01 |
| Normal-vs-Female |
5.465400E-01 |
| Male-vs-Female |
4.961000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.150400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.547000E-01 |
| Normal-vs-Age(61-80Yrs) |
5.792400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.527400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.939840E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.148200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.823600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.333200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.783200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.226600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.063000E-01 |
| Classical-VS-Follicular |
1.641560E-04 |
| Classical-VS-Other |
9.918200E-01 |
| Classical-VS-Normal |
9.256200E-02 |
| Tall-VS-Follicular |
4.162000E-02 |
| Tall-VS-Other |
7.764400E-01 |
| Tall-VS-Normal |
4.817600E-01 |
| Follicular-VS-Other |
2.492800E-01 |
| Follicular-VS-Normal |
2.256400E-01 |
| Other-VS-Normal |
4.798200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.757400E-01 |
| Normal-vs-N1 |
3.867600E-01 |
| N0-vs-N1 |
4.453000E-01 |
|
|
